These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 14587199)
1. [Therapeutic index makes easier the choice of admissible substances. No fear concerning cortisone]. MMW Fortschr Med; 2003 Jul; 145(27-28):64. PubMed ID: 14587199 [No Abstract] [Full Text] [Related]
2. In vivo assessment of the atrophogenic potency of mometasone furoate, a newly developed chlorinated potent topical glucocorticoid as compared to other topical glucocorticoids old and new. Kerscher MJ; Hart H; Korting HC; Stalleicken D Int J Clin Pharmacol Ther; 1995 Apr; 33(4):187-9. PubMed ID: 7620686 [TBL] [Abstract][Full Text] [Related]
3. Superior nuclear receptor selectivity and therapeutic index of methylprednisolone aceponate versus mometasone furoate. Mirshahpanah P; Döcke WD; Merbold U; Asadullah K; Röse L; Schäcke H; Zollner TM Exp Dermatol; 2007 Sep; 16(9):753-61. PubMed ID: 17697148 [TBL] [Abstract][Full Text] [Related]
4. Mometasone furoate ointment 0.1% vs. hydrocortisone ointment 1.0% in psoriasis. Atrophogenic potential. Katz HI; Prawer SE; Watson MJ; Scull TA; Peets EA Int J Dermatol; 1989 Jun; 28(5):342-4. PubMed ID: 2753592 [No Abstract] [Full Text] [Related]
5. Comparison of the local and systemic side effects of methylprednisolone aceponate and mometasone furoate applied as ointments with equal antiinflammatory activity. Kecskés A; Heger-Mahn D; Kuhlmann RK; Lange L J Am Acad Dermatol; 1993 Oct; 29(4):576-80. PubMed ID: 8408793 [TBL] [Abstract][Full Text] [Related]
6. Mometasone furoate. Am J Health Syst Pharm; 2001 Nov; 58(22):2140-1. PubMed ID: 11760915 [No Abstract] [Full Text] [Related]
7. Comparison of skin atrophy and vasoconstriction due to mometasone furoate, methylprednisolone and hydrocortisone. Hoffmann K; Auer T; Stücker M; Hoffmann A; Altmeyer P J Eur Acad Dermatol Venereol; 1998 Mar; 10(2):137-42. PubMed ID: 9553910 [TBL] [Abstract][Full Text] [Related]
8. [Allergic rhinitis. Topical steroids without systemic effect]. Maegele M Med Monatsschr Pharm; 1999 Mar; 22(3):89-90. PubMed ID: 10223869 [No Abstract] [Full Text] [Related]
9. Limited application of mometasone furoate on the face and intertriginous areas: analysis of safety and efficacy. Lebwohl M; Peets E; Chen V Int J Dermatol; 1993 Nov; 32(11):830-1. PubMed ID: 8270349 [No Abstract] [Full Text] [Related]
10. Topical glucocorticoids with improved benefit/risk ratio: do they exist? Korting HC; Kerscher MJ; Schäfer-Korting M J Am Acad Dermatol; 1992 Jul; 27(1):87-92. PubMed ID: 1619082 [TBL] [Abstract][Full Text] [Related]
11. Mometasone furoate lotion once daily versus triamcinolone acetonide lotion twice daily in psoriasis. Swinehart JM; Barkoff JR; Dvorkin D; Fisher G; Peets E Int J Dermatol; 1989 Dec; 28(10):680-1. PubMed ID: 2687182 [No Abstract] [Full Text] [Related]
13. Mometasone fuoroate 0.1% ointment in the treatment of vulvar lichen sclerosus: a study of efficacy and safety on a large cohort of patients. Virgili A; Borghi A; Minghetti S; Corazza M J Eur Acad Dermatol Venereol; 2014 Jul; 28(7):943-8. PubMed ID: 23879234 [TBL] [Abstract][Full Text] [Related]
15. Investigator-masked comparison of tazarotene gel q.d. plus mometasone furoate cream q.d. vs. mometasone furoate cream b.i.d. in the treatment of plaque psoriasis. Koo JY; Martin D Int J Dermatol; 2001 Mar; 40(3):210-2. PubMed ID: 11422529 [No Abstract] [Full Text] [Related]
16. Mometasone versus betamethasone creams: a trial in dermatoses. Wishart JM; Lee IS N Z Med J; 1993 May; 106(956):203-5. PubMed ID: 8341439 [TBL] [Abstract][Full Text] [Related]
17. [Contribution on the local application of corticosteroids]. Schieferstein G Z Haut Geschlechtskr; 1966 Nov; 41(9):354-63. PubMed ID: 5995307 [No Abstract] [Full Text] [Related]
18. Mometasone furoate nasal spray for allergic rhinitis. Med Lett Drugs Ther; 1999 Feb; 41(1046):16-7. PubMed ID: 10050178 [No Abstract] [Full Text] [Related]
19. [Corticosteroids for treatment of rheumatoid arthritis]. Tanaka Y Nihon Rinsho; 2005 Jan; 63 Suppl 1():468-71. PubMed ID: 15799401 [No Abstract] [Full Text] [Related]